ArticleProceedings of the National Academy of Sciences of the United States of America2020

Remdesivir targets a structurally analogous region of the Ebola virus and SARS-CoV-2 polymerases.

Michael K Lo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.